A pilot study of clinical cell therapies in Alzheimer’s disease

Journal of Neurorestoratology - Tập 9 - Trang 269-284 - 2021
Xiaoling Guo1, Yunliang Wang2, Yan Li1, Yanqiu Liu2, Ying Liu3, Di Chen4, Juan Xiao4, Wenyong Gao4, Bo Zhou1, Yajun Liu2, Ran Liu2, Weidong Chen5, Fei Liu6, Deqiang Guo6, Gensheng Mao3, Hongyun Huang4
1Neurological Department, The 981st Hospital of Chinese PLA, Chengde, 067000, Hebei, China
2Neurological Center, The 960th Hospital of Chinese PLA, Zibo, 255300, Shandong, China
3Institute of Neurorestoratology, The Third Medical Center of the General Hospital of the PLA, Beijing, 100039, China
4Beijing Hongtianji Neuroscience Academy, Beijing, 100143, China
5E.N.T. Department, The 981st Hospital of Chinese PLA, Chengde, 067000, Hebei, China
6E.N.T. Department, The 960th Hospital of Chinese PLA, Zibo, 255300, Shandong, China

Tài liệu tham khảo

Duncan, 2017, Alzheimer's disease, dementia, and stem cell therapy, Stem Cell Res Ther, 8, 111, 10.1186/s13287-017-0567-5 Brookmeyer, 2018, Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States, Alzheimers Dement, 14, 121, 10.1016/j.jalz.2017.10.009 Hane, 2017, Recent progress in Alzheimer's disease research, part 3: diagnosis and treatment, J Alzheimers Dis, 57, 645, 10.3233/JAD-160907 Stamegna, 2018, Grafts of olfactory stem cells restore breathing and motor functions after rat spinal cord injury, J Neurotrauma, 35, 1765, 10.1089/neu.2017.5383 Bonnet, 2020, Immediate or delayed transplantation of a vein conduit filled with nasal olfactory stem cells improves locomotion and axogenesis in rats after a peroneal nerve loss of substance, Int J Mol Sci, 21, 10.3390/ijms21082670 Wang, 2020, Olfactory ensheathing cells in chronic ischemic stroke: a phase 2, double- blind, randomized, controlled trial, J Neurorestoratol, 8, 182, 10.26599/JNR.2020.9040019 Guo, 2019, Olfactory ensheathing cell transplantation improving cerebral infarction sequela: a case report and literature review, J Neurorestoratol, 7, 82, 10.26599/JNR.2019.9040009 Huang, 2020, Standards of clinical-grade olfactory ensheathing cell culture and quality control (2020 China Version), J Neurorestoratol, 8, 217, 10.26599/JNR.2020.9040023 Holbrook, 2011, Immunohistochemical characterization of human olfactory tissue, Laryngoscope, 121, 1687, 10.1002/lary.21856 Lu, 2017, Differentiation of human olfactory mucosa mesenchymal stem cells into photoreceptor cells in vitro, Int J Ophthalmol, 10, 1504 Zhou, 2012, Transplantation of autologous activated Schwann cells in the treatment of spinal cord injury: six cases, more than five years of follow-up, Cell Transplant, 21, S39, 10.3727/096368912X633752 Saberi, 2008, Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes, Neurosci Lett, 443, 46, 10.1016/j.neulet.2008.07.041 Saberi, 2011, Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases, J Neurosurg Spine, 15, 515, 10.3171/2011.6.SPINE10917 van Horne, 2018, Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's disease during deep brain stimulation surgery: 1-year follow-upstudy of safety, feasibility, and clinical outcome, J Neurosurg, 129, 1550, 10.3171/2017.8.JNS163222 Huang, 2012, Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury, Cell Transplant, 21, S23, 10.3727/096368912X633734 Tabakow, 2014, Functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging, Cell Transplant, 23, 1631, 10.3727/096368914X685131 Huang, 2009, Olfactory ensheathing cells transplantation for central nervous system diseases in 1, 255 patients (in Chinese), Chin J Reparative Reconstr Surg, 23, 14 Huang, 2020, Clinical neurorestorative cell therapies: Developmental process, current state and future prospective, J Neurorestoratol, 8, 61, 10.26599/JNR.2020.9040009 Vaquero, 2019, Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer's type dementia, Cytotherapy, 21, 428, 10.1016/j.jcyt.2019.02.009 Huang, 2019, 2018 yearbook of neurorestoratology, J Neurorestoratol, 7, 11, 10.26599/JNR.2019.9040003 Huang, 2020, The 2019 yearbook of Neurorestoratology, J Neurorestoratol, 8, 1, 10.26599/JNR.2020.9040004 Huang, 2021, The 2020 Yearbook of Neurorestoratology, J Neurorestoratol, 9, 1, 10.26599/JNR.2021.9040002